semaglutide gastrointestinal obstruction class action in louisiana bowel west virginia Wegovy Lawsuit Lawyer louisiana semaglutide gastrointestinal obstruction law

Associations Between Weight Loss and Gastrointestinal Adverse Events on GLP-1RA Therapy While gastrointestinal adverse events that occur with GLP-1RAs are mainly mild-to-moderate and transient, occurring particularly during dose escalation, there may be concerns that GLP-1RA-mediated weight loss could be due to these effects

But there are a few things worth understanding before you assume this is your best option

DKA, diabetic ketoacidosis

The future of diabetes and obesity management looks incredibly promising with these advancements, creating a new era of metabolic health

Compounding of semaglutide is also subject to FDA rules that have tightened since the semaglutide shortage was declared resolved in 2025, so availability is not guaranteed and depends on regulatory and supply conditions